13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001325083
Total reported value
$179.3M
$179.3M
33 檔
52.3%
The Q4 2025 SEC filing reveals that Knoll Capital Management, LLC held a total portfolio value of $179.3M, covering 33 public equity positions.
In Q4 2025, Knoll Capital Management, LLC adopted a defensive or profit-taking posture, trimming 1 positions and completely liquidating 6 holdings to manage risk exposure.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | ALDX | Aldeyra Therapeutics Inc | Stock-Other | 13.01% | +1.36% | — | |
| 2 | BHVN | Biohaven Ltd. | Stock-Other | 12.06% | -10.93% | +160.10% | |
| 3 | NUVB | Nuvation Bio Inc | Stock-Other | 6.16% | +1.49% | +46.20% | |
| 4 | ✓ | Avadel Pharmaceuticals PLC ADR | Stock-Other | 5.93% | — | — | |
| 5 | GLD | Spdr Gold Shares | ETF-Commodities | 5.82% | — | — | |
| 6 | RGLD | Royal Gold Inc | Stock-Materials | 5.38% | -1.58% | +486.11% | |
| 7 | KGC | Kinross Gold CORP | Stock-Materials | 5.30% | -1.20% | — | |
| 8 | ✓ | Entera Bio LTD | Stock-Other | 5.23% | +2.22% | — | |
| 9 | MGTX | MeiraGTx Holdings plc | Stock-Other | 4.56% | +3.41% | — | |
| 10 | SEA1EUR | Seabridge Gold Inc | Stock-Other | 4.30% | -0.44% | — | |
| 11 | AEM | Agnico Eagle Mines LTD | Stock-Materials | 4.10% | -1.38% | — | |
| 12 | OCUL | Ocular Therapeutix Inc | Stock-Other | 3.34% | +3.48% | — | |
| 13 | CGAU | Centerra Gold Inc | Stock-Other | 3.28% | -0.36% | — | |
| 14 | SSRM | Ssr Mining Inc | Stock-Materials | 2.46% | -0.14% | — | |
| 15 | PAAS | Pan American Silver CORP | Stock-Materials | 2.38% | -0.53% | — | |
| 16 | FNV | Franco-nevada CORP | Stock-Materials | 2.38% | -0.67% | — | |
| 17 | SLV | Ishares Silver Trust | ETF-Commodities | 2.36% | — | — | |
| 18 | ELTX | Elicio Therapeutics Inc | Stock-Other | 2.30% | -1.10% | — | |
| 19 | ALT | Altimmune Inc | Stock-Other | 1.86% | — | — | |
| 20 | TFPM | Triple Flag Precious Met | Stock-Materials | 0.90% | -0.30% | — | |
| 21 | AGI | Alamos Gold Inc-class A | Stock-Materials | 0.88% | -0.38% | — | |
| 22 | CDE | Coeur Mining Inc | Stock-Materials | 0.79% | -0.12% | — | |
| 23 | NEWP | New Pacific Metals CORP | Stock-Other | 0.78% | -0.02% | — | |
| 24 | ITA | Ishares U.s. Aerospace & Def | ETF-Other | 0.75% | +0.10% | — | |
| 25 | PM | Philip Morris International | Stock-Consumer Staples | 0.74% | +0.09% | — | |
| 26 | WPM | Wheaton Precious Metals CORP | Stock-Materials | 0.67% | -0.13% | — | |
| 27 | ABEO | Abeona Therapeutics Inc | Stock-Other | 0.57% | +0.46% | +276.39% | |
| 28 | NOC | Northrop Grumman CORP | Stock-Industrials | 0.57% | -0.20% | — | |
| 29 | BAH | Booz Allen Hamilton Holdings | Stock-Industrials | 0.50% | +2.62% | — | |
| 30 | DC | Dakota Gold CORP | Stock-Other | 0.32% | -0.05% | — | |
| 31 | APLT | Applied Therapeutics Inc | Stock-Other | 0.28% | — | -22.43% | |
| 32 | CRDL | Cardiol Therapeutics Inc-a | Stock-Other | 0.04% | -0.07% | EXIT | |
| 33 | ✓ | Orgenesis, Inc. | Stock-Other | — | -0.01% | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | BHVN | Biohaven Ltd. | +4.9% | +160.10% | Add |
| 2 | RGLD | Royal Gold Inc | +4.4% | +486.11% | Add |
| 3 | NUVB | Nuvation Bio Inc | +3.2% | +46.20% | Add |
| 4 | ✓ | Avadel Pharmaceuticals PLC ADR | +1% | — | Unchanged |
| 5 | SLV | Ishares Silver Trust | +0.5% | — | Unchanged |
| 6 | CGAU | Centerra Gold Inc | +0.4% | — | Unchanged |
| 7 | ABEO | Abeona Therapeutics Inc | +0.4% | +276.39% | Add |
| 8 | PAAS | Pan American Silver CORP | +0.3% | — | Unchanged |
| 9 | SEA1EUR | Seabridge Gold Inc | +0.2% | — | Unchanged |
| 10 | NEWP | New Pacific Metals CORP | +0.1% | — | Unchanged |
| 11 | DC | Dakota Gold CORP | 0% | — | Unchanged |
| 12 | TFPM | Triple Flag Precious Met | 0% | — | Unchanged |
| 13 | CRDL | Cardiol Therapeutics Inc-a | 0% | — | Unchanged |
| 14 | ✓ | Orgenesis, Inc. | 0% | — | Unchanged |
| 15 | AGI | Alamos Gold Inc-class A | -0.1% | — | Unchanged |
| 16 | WPM | Wheaton Precious Metals CORP | -0.1% | — | Unchanged |
| 17 | ITA | Ishares U.s. Aerospace & Def | -0.1% | — | Unchanged |
| 18 | PM | Philip Morris International | -0.1% | — | Unchanged |
| 19 | NOC | Northrop Grumman CORP | -0.1% | — | Unchanged |
| 20 | KGC | Kinross Gold CORP | -0.2% | — | Unchanged |
| 21 | CDE | Coeur Mining Inc | -0.2% | — | Unchanged |
| 22 | BAH | Booz Allen Hamilton Holdings | -0.2% | — | Unchanged |
| 23 | GLD | Spdr Gold Shares | -0.3% | — | Unchanged |
| 24 | ALT | Altimmune Inc | -0.4% | — | Unchanged |
| 25 | OCUL | Ocular Therapeutix Inc | -0.4% | — | Unchanged |
| 26 | FNV | Franco-nevada CORP | -0.6% | — | Unchanged |
| 27 | AEM | Agnico Eagle Mines LTD | -0.7% | — | Unchanged |
| 28 | ✓ | Entera Bio LTD | -0.8% | — | Unchanged |
| 29 | MGTX | MeiraGTx Holdings plc | -1% | — | Unchanged |
| 30 | ELTX | Elicio Therapeutics Inc | -1.4% | — | Unchanged |
| 31 | APLT | Applied Therapeutics Inc | -2.2% | -22.43% | Trim |
| 32 | ALDX | Aldeyra Therapeutics Inc | -2.3% | — | Unchanged |
| 33 | AYS1 | Sandstorm Gold LTD | — | EXIT | Sold out |
| 34 | SSRM | Ssr Mining Inc | — | NEW | New buy |
| 35 | V | Visa Inc-class A Shares | — | EXIT | Sold out |
| 36 | DEO | Diageo Plc-sponsored Adr | — | EXIT | Sold out |
| 37 | MREO | Mereo Biopharma Group Pl-adr | — | EXIT | Sold out |
| 38 | ✓ | Hookipa Pharma | — | EXIT | Sold out |
| 39 | OBIO | Orchestra Biomed Holdings In | — | EXIT | Sold out |
According to official SEC Form 13F filings, Knoll Capital Management, LLC reported a total U.S. public equity portfolio value of $179.3M across 33 disclosed positions in Q4 2025.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including ALDX, BHVN, NUVB) accounted for 52.3% of total reported equity market value during Q4 2025.
Top New Position Initiated
SSRM
市值: $5.4M
Top Position Liquidated / Trimmed
AYS1
前期市值: $8.8M
During Q4 2025, Knoll Capital Management, LLC's top holdings by market value included ALDX (13.0%)、BHVN (12.1%)、NUVB (6.2%). The largest single position, ALDX, represented 13.0% of total portfolio value.
In Q4 2025, Knoll Capital Management, LLC made 12 total portfolio adjustments, initiating 1 new buys, adding to 4 positions, trimming 1 holdings, and fully liquidating 6 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.